Back to signals
FDA device recallVulnerabilitiesPublished April 29, 2026
Beta Bionics, Inc.: Alternate Controller Enabled Insulin Infusion Pump
insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
Open the source record- Tags
- FDA recall, medical device, class 2, Clinical Chemistry, Software change control, Open, Classified
- Related exam domains
- CISSP 3: Security Architecture and Engineering; CISSP 4: Communication and Network Security; CISSP 7: Security Operations; CISM 3: Information Security Program
- Source record id
- Z-1996-2026
- First seen by InfoSec Signals
- 9/23/2026
Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.